MEDICINES CO /DE Indefinite-lived Intangible Assets (Excluding Goodwill)
MEDICINES CO /DE had Indefinite-lived Intangible Assets (Excluding Goodwill) of $0 as of 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill · last filed 2018-03-01
- 2017-12-31: Indefinite-lived Intangible Assets (Excluding Goodwill) $0.00.
- 2017-09-30: Indefinite-lived Intangible Assets (Excluding Goodwill) $0.00.
- 2017-06-30: Indefinite-lived Intangible Assets (Excluding Goodwill) $188.62M.
- 2017-03-31: Indefinite-lived Intangible Assets (Excluding Goodwill) $253.62M.
| Period end | Indefinite-lived Intangible Assets (Excluding Goodwill) | Indefinite-lived Intangible Assets (Excluding Goodwill) as first filed |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-01 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $188.62M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $253.62M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $65.00M 10-K · filed 2018-03-01 | $253.62M 10-K · filed 2017-03-01 |
| 2016-09-30 | $253.62M 10-Q · filed 2016-10-27 | |
| 2016-06-30 | $253.62M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $253.62M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $253.62M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $253.62M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $253.62M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $715.68M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $474.68M 10-K · filed 2016-02-29 | $712.68M 10-K · filed 2015-03-02 |
| 2014-09-30 | $782.18M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $782.18M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $782.18M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $782.18M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $557.50M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $391.50M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $380.60M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $69.50M 10-K · filed 2014-03-03 | |
| 2011-12-31 | $69.50M 10-K · filed 2013-03-01 |